Production of interleukin-12 as a self-processing 2A polypeptide

Journal of Interferon and Cytokine Research

Volumn 19, Issue 3, 1999, Pages 235-241

  Chaplin, Paul J ^a,b   Camon, Evelyn B ^a   Villarreal Ramos, Barnardo ^a   Flint, Micheal ^c   Ryan, Martin D ^c   Collins, Robert A ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b CSIRO   (Australia)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; INTERLEUKIN 12; POLYPEPTIDE;

ANIMAL CELL; ARTICLE; CATTLE; CERCOPITHECIDAE; CYTOKINE PRODUCTION; FOOT AND MOUTH DISEASE VIRUS; GENE; LYMPHOBLAST; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CATTLE; CELLS, CULTURED; COS CELLS; GENETIC VECTORS; HUMANS; INTERLEUKIN-12; PROTEIN PROCESSING, POST-TRANSLATIONAL; VIRAL PROTEINS;

EID: 0032946020     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099314162     Document Type: Article

References (25)

1. KINIWA, M., GATELY, M., GUBLER, U., CHIZZONITE, R., FARGEAS, C., and DELESPESSE, G. (1992). Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J. Clin. Invest. 90, 262-266.
2. + T cells from α/β TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFNγ production is IFNγ-dependent. Int. Immunol. 5, 1119-1128.
3. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDAN, R., SHERMAN, F., PERUSSI, B., and TRINCHIERI, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF): cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
4. GATELY, M.K., WARRIER, R.R., HONASOGE, S., CARVAJAL, D.M., FAHERTY, D.A., CONNAUGHTON, S.E., ANDERSON, T.D., SARMIENTO, U., HUBBARD, B.R., and MURPHY, M. (1994). Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFNγ in vivo. Int. Immunol. 6, 157-167.
5. HEINZEL, F.P., SCHOENHAUT, D.S., RERKO, R.M., ROSSER, L.E., and GATELY, M.K. (1993). Recombinant interleukin-12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509.
6. TRIPP, C.S., GATELY, M.K., HAKIMI, J., LING, P., and UNANUE, E.R. (1994). Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFNγ. J. Immunol. 152, 1883-1887.
7. KHAN, I.A., MATSUURA, T., and KASPER, L.H. (1994). Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62, 1639-1642.
8. GUBLER, U., CHUA, A.O., SCHOENHAUT, D.S., DWYER, C.M., MCCOMAS, W., MOTYKA, R., NABAVI, N., WOLITZKY, A.G., QUINN, P.M., FAMILLETTI, P.C., and GATELY, M.K. (1991). Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88, 4143-4147.
9. RAKHMILEVICH, A.L., TURNER, J., FORD, M.J., MCCABE, D., SUN, W.H., SONDEL, P.M., GROTA, K., and YANG, N.S. (1996). Gene gun-mediated skin transfected with interleukin 12 gene results in regression of established primary and metastatic murine tumours. Proc. Natl. Acad. Sci. USA 93, 6291-6296.
10. BRAMSON, J., HITT, M., GALLICHAN, W.S., ROSENTHAL, K.L., GAULDIE, J., and GRAHAM, F.L. (1996). Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. Hum. Gene Ther. 7, 333-342.
11. D'ANDREA, A., RENGARAJU, M., VALIANTE, N.M., CHEHIMI, J., KUBIN, M., ASTE, M., CHAN, S.H., KOBAYASHI, M., YOUNG, D., NICKBARG, E., CHIZZONITE, R., WOLF, S.F., and TRINCHIERI, G. (1992). Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J. Exp. Med. 176, 1387-1398.
12. GILLESSEN, S., CARVAJAL, D., LING, P., PODLASKJ, F.J., STREMLO, D.L., FAMILLETTI, P.C., GUBLER, U., PRESKY, D.H., STERN, A.S., and GATELY, M.K. (1995). Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25, 200-206.
13. RUECKERT, R.R. (1996). Picornaviridae: the viruses and their replication. In: Fields Virology, 3rd ed. B.N. Fields, D.M. Knipe, P.M. Howley, R.M. Chanock, J.L. Melinck, and T.P. Monath (eds.) Philadelphia: Lippincott-Raven, pp. 477-522.
14. RYAN, M.D., KING, A.M.Q., and THOMAS, P.G. (1991). Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J. Gen. Virol. 72, 2727-2732.
15. RYAN, M.D., and DREW, J. (1994). Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J. 13, 928-933.
16. ZARLENGA, D.S., CANALS, A., ASCHENBRENNER, R.A., and GASBARRE, L.C. (1995). Enzymatic amplification and molecular cloning of cDNA encoding the small and large subunits of bovine interleukin 12. Biochim. Biophys. Acta 1270, 215-217.
17. LINSLEY, P.S., BRADY, W., GROSMAIRE, L., ARUFFO, A., DAMLE, N.K., and LEDBETTER, J.A. (1991). Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173, 721-730.
18. COLLINS, R.A., TAYTON, H.K., GELDER, K.I., BRITTON, P., and OLDHAM, G. (1994). Cloning and expression of bovine and porcine interleukin-2 in baculovirus and analysis of cross-species reactivity. Vet. Immunol. Immunopathol. 40, 313-324.
19. MATZINGER, P. (1991). The JAM test: a simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145, 185-192.
20. WOLF, S.F., TEMPLE, P.A., KOBAYASHI, M., YOUNG, D., DICIG, M., LOWE, L., DZIALO, R., FITZ, L., FERENZ, C., HEWICK, R.M., KELLEHER, K., HERRMANN, S.H., CLARK, S.C., AZZONI, L., CHAN, S.H., TRINCHIERI, G., and PERUSSIA, B. (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146, 3074-3081.
21. SCHOENHAUT, D.S., CHUA, A.O., WOLITZKY, A.G., QUINN, P.M., DWYER, C.M., MCCOMAS, W., FAMILLETTI, P.C., GATELY, M.K., and GUBLER, U. (1992). Cloning and expression of murine IL-12. J. Immunol. 148, 3433-3440.
22. CULLEN, B.R., LOMEDICO, P.T., and JU, G. (1984). Transcriptional interference in avian retroviruses-implications for the promoter insertion model of leukoemogenesis. Nature 307, 241-245.
23. ZITVOGEL, L., TAHARA, H., CAI, Q., STORKUS, W.J., MULLER, G., WOLF, S.F., GATELY, M., ROBBINS, P.D., and LOTZE, M.T. (1994). Construction and characterization of retroviral vectors expressing biologically active human IL-12. Hum. Gene Ther. 5, 1493-1506.
24. GHATTAS, I.R., SANES, J.R., and MAJORS, I.E. (1991). The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol. 11, 5848-5859.
25. ROOSIEN, J., BELSHAM, G.J., RYAN, M.D., KING, A.M., and VLAK, J.M. (1990). Synthesis of foot and mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J. Gen. Virol. 71, 1703-1711.